Data in this study support the conclusion that the exposure of prostate cancer cells to CCM from HS-5 cells in which GPC-1 was inhibited increases the acquisition of a mesenchymal phenotype and increases the rate of cell migration after wound healing. The gene discussed is GPC1; the disease is prostate carcinoma.